tiprankstipranks
Acorda Therapeutics (ACORQ)
OTHER OTC:ACORQ
Holding ACORQ?
Track your performance easily

Acorda Therapeutics (ACORQ) Stock Price & Analysis

599 Followers

ACORQ Stock Chart & Stats


Financials

Annual

Risk Analysis

Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks

Website Traffic

Sorry, No Data Available
There is no website visitor data available for this stock.
---

ACORQ FAQ

What was Acorda Therapeutics’s price range in the past 12 months?
Acorda Therapeutics lowest stock price was $0.01 and its highest was $18.00 in the past 12 months.
    What is Acorda Therapeutics’s market cap?
    Currently, no data Available
    When is Acorda Therapeutics’s upcoming earnings report date?
    Acorda Therapeutics’s upcoming earnings report date is Nov 05, 2024 which is 17 days ago.
      How were Acorda Therapeutics’s earnings last quarter?
      Currently, no data Available
      Is Acorda Therapeutics overvalued?
      According to Wall Street analysts Acorda Therapeutics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
        Does Acorda Therapeutics pay dividends?
        Acorda Therapeutics does not currently pay dividends.
        What is Acorda Therapeutics’s EPS estimate?
        Acorda Therapeutics’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Acorda Therapeutics have?
        Acorda Therapeutics has 1,242,000 shares outstanding.
          What happened to Acorda Therapeutics’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Acorda Therapeutics?
          Among the largest hedge funds holding Acorda Therapeutics’s share is Canyon Capital Advisors LLC. It holds Acorda Therapeutics’s shares valued at N/A.
            ---

            Acorda Therapeutics Stock Smart Score

            10
            Unlock Smart Score
            1
            2
            3
            4
            5
            6
            7
            8
            9
            10

            Fundamentals

            Return on Equity
            Trailing 12-Months
            Asset Growth
            -78.24%
            Trailing 12-Months

            Company Description

            Acorda Therapeutics

            Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.
            ---

            ACORQ Company Deck

            ---

            ACORQ Earnings Call

            Q3 2023
            0:00 / 0:00
            ---
            Similar Stocks
            Company
            Price & Change
            Follow
            Axsome Therapeutics
            Blueprint Medicines
            Amicus
            Kala Pharmaceuticals
            Popular Stocks
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis